Introducing: Conversations on Commercialization
About this episode
The episode introduces a new spinoff podcast focusing on commercialization decisions in biopharma.
Commercialization decisions are shaping success earlier than ever in the product lifecycle, from value and access to launch strategy, deployment and stakeholder engagement. Conversations on Commercialization, a new spinoff of the Syneos Health Podcast, explores what this shift means for biopharma companies and what it takes to compete in a rapidly evolving market. Led by Tyler Cowan, Commercial Vice President at Syneos Health, and joined by a bench of expert co-hosts, the podcast brings...
People in this episode
Host: Tyler Cowan
Topics covered
- commercialization
- biopharma
- product lifecycle
- launch strategy
- stakeholder engagement
Keywords
- commercialization
- biopharma
- product lifecycle
- launch strategy
- stakeholder engagement
Mentioned in this episode
Organizations: Syneos Health, biopharma companies
More episodes of The Syneos Health Podcast
- Site Realities Series | Navigating Complexity: Communication, Escalation Paths and Site Partnership at Scale
- Site Realities Series | Building Trust at the Site Level: The CRA as Ambassador and Partner
- Site Realities Series | From Monitor to Strategic Partner: The Evolution of the CRA Role
- Conversations on Commercialization: Navigating Dermatology’s New Access Landscape with Paul Rittman of Almirall US
- Functionally Speaking Series: Regulatory Intelligence, Medical Writing and the AI Inflection Point
- Functionally Speaking Series: Reimagining Site Experience: CRAs, AI and the Future of Functional Models
Explore listener stats, chart rankings, contacts and more on the The Syneos Health Podcast podcast page.